Home

J KIMO ESPLIN

CIK 1276716 · Exec VP, Strategy & Investment · last filed 2018-08-03

J KIMO ESPLIN is an Exec VP, Strategy & Investment who has filed 159 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for HUN, was dated Aug 3, 2018. Across all open-market trades the lifetime net is −$22.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.6M across reported positions. 57 SEC filings were submitted jointly with Huntsman CORP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.55M

Companies

2

Total Filings

159

Lifetime Open-Market Net

-$22.59M

Filer Profile

Reported Address
C/O NUTRACEUTICAL INTERNATIONAL CORP
1400 KEARNS BLVD
PARK CITY, UT 84060
Related Filers
Huntsman CORP — 57 joint filings, latest 2018-08-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HUN Exec VP, Strategy & Investment 369,210 $9.62 $3.55M -$22.47M 45 2018-08-03
NUTRACEUTICAL INTERNATIONAL CORP (NUTR) Delisted Director 0 — — -$119.2K 112 2017-08-24

Recent Filings

159 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-08-03 HUN Gift (G) −13,657 $0 EDGAR
2018-05-17 HUN Sell (S) −16,106 -$526.5K EDGAR
2018-05-17 HUN Sell (S) −34,399 -$1.09M EDGAR
2018-02-09 HUN Mixed +3,527 $0 EDGAR
2018-02-05 HUN Tax (F) −7,187 -$233.3K EDGAR
2017-12-07 HUN Mixed — -$3.67M EDGAR
2017-11-01 HUN Mixed — -$12.40M EDGAR
2017-08-24 NUTRACEUTICAL INTERNATIONAL CORP (NUTR) Delisted Disp (D) −11,127 $0 EDGAR
2017-05-08 NUTRACEUTICAL INTERNATIONAL CORP (NUTR) Delisted Grant (A) +31 $1.0K EDGAR
2017-04-10 NUTRACEUTICAL INTERNATIONAL CORP (NUTR) Delisted Grant (A) +32 $1.0K EDGAR
Showing 1–10 of 159
Page 1 of 16
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.